Pharmacology Research Today is a free monthly online journal that collates and summarizes the latest research about Pharmacology, including details on pharmacogenomics, drug development, new medications.

Volume 1 (2005), Issue 4 (November)

1. Combinatorial pharmacogenetics.
   Nat Rev Drug Discov, 4(11): 911-8. [Abstract] [Full-text]
2. The role of the benchmark dose in a regulatory context.
   Regul Toxicol Pharmacol, 43(3): 280-91. [Abstract] [Full-text]
3. Pharmacogenomics of statin responsiveness.
   Am J Cardiol, 96(9): 65K-70K; discussion 34K-35K. [Abstract] [Full-text]
4. Implications of pharmacogenomics for drug development and clinical practice.
   Arch Intern Med, 165(20): 2331-6. [Abstract] [Full-text]
5. Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxel.
   Clin Cancer Res, 11(22): 8097-104. [Abstract] [Full-text]
6. Pharmacogenetics and anesthesiologists.
   Pharmacogenomics, 6(8): 849-56. [Abstract] [Full-text]
7. Multifactor dimensionality reduction for detecting gene-gene and gene-environment interactions in pharmacogenomics studies.
   Pharmacogenomics, 6(8): 823-34. [Abstract] [Full-text]
8. Flavin-containing monooxygenase genetic polymorphism: impact on chemical metabolism and drug development.
   Pharmacogenomics, 6(8): 807-22. [Abstract] [Full-text]
9. Natural cannabinoids: templates for drug discovery.
   Life Sci, 78(5): 454-66. [Abstract] [Full-text]
10. Drug discovery from medicinal plants.
    Life Sci, 78(5): 431-41. [Abstract] [Full-text]
11. Systems and integrative biology as alternative guises for pharmacology: prime time for an iPharm concept?
    Biochem Pharmacol, 70(12): 1707-16. [Abstract] [Full-text]
12. Individualised cancer therapeutics: dream or reality?
    Expert Opin Ther Targets, 9(6): 1189-201. [Abstract] [Full-text]
13. Can herbs provide a new generation of drugs for treating Alzheimer's disease?
    Brain Res Brain Res Rev, 50(2): 361-76. [Abstract] [Full-text]
14. Racializing drug design: implications of pharmacogenomics for health disparities.
    Am J Public Health, 95(12): 2133-8. [Abstract] [Full-text]
15. Mixed effects versus fixed effects modelling of binary data with inter-subject variability.
    J Pharmacokinet Pharmacodyn, 32(2): 245-60. [Abstract] [Full-text]
16. Non-linear mixed effects modeling - from methodology and software development to driving implementation in drug development science.
    J Pharmacokinet Pharmacodyn, 32(2): 161-83. [Abstract] [Full-text]
17. How modeling and simulation have enhanced decision making in new drug development.
    J Pharmacokinet Pharmacodyn, 32(2): 185-97. [Abstract] [Full-text]
18. Conditioning on certain random events associated with statistical variability in PK/PD.
    J Pharmacokinet Pharmacodyn, 32(2): 213-43. [Abstract] [Full-text]
19. Factors determining the optimal body site and method for obtaining punch biopsies of human skin as a tissue in which to assess pharmacodynamic and pharmacokinetic endpoints in drug development studies.
    Cancer Chemother Pharmacol, 57(1): 52-8. [Abstract] [Full-text]
20. A herbal medicine for the treatment of lung cancer.
    Mol Cell Biochem, 280(1): 125-33. [Abstract] [Full-text]
21. Supervised self-organizing maps in drug discovery. 1. Robust behavior with overdetermined data sets.
    J Chem Inf Model, 45(6): 1749-58. [Abstract] [Full-text]
22. Separation and determination of tetrandrine and fangchinoline in herbal medicines by flow injection-micellar electrokinetic capillary chromatography with internal standard method.
    J Chromatogr A, 1098(1): 177-82. [Abstract] [Full-text]
23. Pharmacogenetics of colorectal cancer.
    Expert Opin Pharmacother, 6(15): 2607-16. [Abstract] [Full-text]
24. Does pharmacogenetics have the potential to allow the individualisation of immunosuppressive drug dosing in organ transplantation?
    Expert Opin Pharmacother, 6(15): 2593-605. [Abstract] [Full-text]
25. The PPAR genes, cardiovascular disease and the emergence of PPAR pharmacogenetics.
    Expert Opin Pharmacother, 6(15): 2577-91. [Abstract] [Full-text]
26. Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy.
    Expert Opin Pharmacother, 6(15): 2565-76. [Abstract] [Full-text]

© 2005-2008 Pharmacology Research Today. All Rights Reserved.